Unknown

Dataset Information

0

COVID-19 and metabolic comorbidities: An update on emerging evidences for optimal therapies.


ABSTRACT: Type 2 diabetes mellitus, obesity, hypertension, and other associated metabolic complications have been demonstrated as a crucial contributor to the enhanced morbidity and mortality of patients with coronavirus disease 2019 (COVID-19). Data on the interplay between metabolic comorbidities and the outcomes in patients with COVID-19 have been emerging and rapidly increasing. This implies a mechanistic link between metabolic diseases and COVID-19 resulting in the exacerbation of the condition. Nonetheless, new evidences are emerging to support insulin-mediated aggressive glucose-lowering treatment as a possible trigger of high mortality rate in diabetic COVID-19 patients, putting the clinician in a confounding and difficult dilemma for the treatment of COVID-19 patients with metabolic comorbidities. Thus, this review discusses the pathophysiological link among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), angiotensin-converting enzyme 2 (ACE2), metabolic complications, and severe inflammation in COVID-19 development, especially in those with multi-organ injuries. We discuss the influence of several routinely used drugs in COVID-19 patients, including anti-inflammatory and anti-coagulant drugs, antidiabetic drugs, renin-angiotensin-aldosterone system inhibitors. Especially, we provide a balanced overview on the clinical application of glucose-lowering drugs (insulin and metformin), angiotensin-converting-enzyme inhibitors, and angiotensin receptor blockers. Although there is insufficient evidence from clinical or basic research to comprehensively reveal the mechanistic link between adverse outcomes in COVID-19 and metabolic comorbidities, it is hoped that the update in the current review may help to better outline the optimal strategies for clinical management of COVID-19 patients with metabolic comorbidities.

SUBMITTER: Hua S 

PROVIDER: S-EPMC8101987 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7441765 | biostudies-literature
| S-EPMC8239852 | biostudies-literature
| S-EPMC7938645 | biostudies-literature
| S-EPMC7352097 | biostudies-literature
| S-EPMC8019074 | biostudies-literature
| S-EPMC7583635 | biostudies-literature
| S-EPMC7857046 | biostudies-literature
| S-EPMC7367788 | biostudies-literature
| S-EPMC7851298 | biostudies-literature